In-Person CME Webcast
1.50 CME/CE Credit
Top Questions in HIV, PTSD, Social Media Advertising
What do primary care clinicians need to know about HIV, PTSD, and social media? Join expert faculty as they review the top questions they get asked about these topics!
CME/CE Information
1.50 AMA PRA Category 1 Credits™ or 1.50 CBRN contact hours or 1.50 AANP, including 0.75 AANP Pharm
Release Date: 4/10/2026
Expiration Date: 5/29/2026
Topics
Learning Objectives
- Discuss how to assess and diagnose post-traumatic stress disorder (PTSD)
- Summarize pharmacological treatments and psychotherapeutic approaches for managing PTSD
- Understand the scope of health-adjacent advertising through social media, discuss the evidence related to some common claims and topics patients may see through social media, and identify reputable, valuable sources to share with patients to ensure quality information
- Discuss indications and recommendations for initiating patients on pre-exposure prophylaxis (PrEP), and summarize current pharmacologic treatments available for those living with HIV
- Apply current guidelines to safely initiate, monitor, and adjust PrEP and HIV treatment regimens in primary care
Faculty
Petros Levounis, MD, MA
Professor and Chair, Department of Psychiatry, Associate Dean, Rutgers New Jersey Medical Center
Director, Northern New Jersey Medication Assisted Treatment Center of Excellence
Past-President, American Psychiatric Association
Chief of Service, University Hospital, Newark, NJ
Learn More
Jillian Joseph, MPAS, PA-C
Assistant Professor, Department of PA Studies, Massachusetts College of Pharmacy, Boston, Massachusetts
Clinical Instructor, Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester, Massachusetts
Learn More
James Quincy Q. Simmons, DNP, MSN, RN, AG/ACNP-BC
Board Certified Nurse Practitioner & Multimedia Medical Expert
Learn MoreDisclosures
All individuals in control of content for this activity (including faculty, moderator, editors, reviewers) have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN contact hours
Accreditation Statement
Provider approved by the California Board of Registered Nursing, Provider Number 17615, for 1.50 contact hours.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 1.50 contact hours of continuing education, which includes 0.75 hours of pharmacology.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.